Extended follow-up of a phase 2 trial of bortezomib alone and in combination with dexamethasone for the frontline treatment of multiple myeloma-Reference-Cited by-同舟云学术

Extended follow-up of a phase 2 trial of bortezomib alone and in combination with dexamethasone for the frontline treatment of multiple myeloma

Published:2009-09 Issue:6 Volume:146 Page:619-626
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Jagannath Sundar,Durie Brian G. M.,Wolf Jeffrey Lee,Camacho Elber S.,Irwin David,Lutzky Jose,McKinley Marti,Potts Phyllis,Gabayan Afshin Eli,Mazumder Amitabha,Crowley John,Vescio Robert

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2009.07803.x/fullpdf

Reference37 articles.

1. Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry. Spanish Registry for Transplant in MM (Grupo Espanol de Trasplante Hematopoyetico-GETH) and PETHEMA;Alegre;Bone Marrow Transplantation,1998

2. Impact of complete remission with intensive therapy in patients with responsive multiple myeloma;Alexanian;Bone Marrow Transplantation,2001

3. Clinically relevant end points and new drug approvals for myeloma;Anderson;Leukemia,2008

4. A phase II study of bortezomib (Velcade®), cyclophosphamide (Cytoxan®), thalidomide (Thalomid®) and dexamethasone as first-line therapy for multiple myeloma;Bensinger;Blood (ASH Meeting Abstracts),2008

5. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant;Bladé;British Journal of Haematology,1998

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myeloma and Leukemia;Oncologic Imaging : a Multidisciplinary Approach;2023

2. Effects of NF-κB manipulation on cancer-associated bone disease;Bone Cancer;2022

3. Multiple myeloma;Journal of Modern Oncology;2021-02-17

4. Proteasome Inhibitors for the Treatment of Multiple Myeloma;Cancers;2020-01-22

5. Proteasome Inhibitors as Sensitizing Agents for Cancer Chemotherapy;Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy;2019